Clinical Trial Update: Nivolumab for Recurrent/Metastatic Carcinosarcoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for nivolumab in recurrent/metastatic carcinosarcoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinosarcoma of the Uterus or Other Sites

Drugs mentioned

• nivolumab (nivolumab)

Snippet

Sponsor: Yonsei University | Conditions: Recurrent/Metastatic Carcinosarcoma | Phase 2 | Status: UNKNOWN